OR WAIT null SECS
Growth and Advancements in Fill/Finish
Employing novel technologies and more patient-centric approaches
Delving into Biopharmaceutical Development and Manufacturing
Quality Considerations in Changing Excipient Providers
May 04, 2023
Presspart will still be responsible for the manufacturing of the Sunriser device.
May 03, 2023
mRNA therapeutics are being researched to support the fight against rare diseases, infectious viruses, and cancers.
The market potential of nucleic acid-based therapies have been pushed into the spotlight following the success of the COVID-19 vaccines.
E&L analytical testing methods can be determined through pointed consideration of the differences small- and large-molecule drug products.
The use of smart tools in early drug discovery can have an impact on downstream phases of drug development.
The development of CAR-T therapies for solid tumor cancers presents a myriad of challenges.
Competition in the organ-on-a-chip market increases as NETRI enters the arena.
May 02, 2023
Quality Quartet Registers connect Quality Quartets to their process system or unit operation “parent.”
User fee programs have improved FDA’s approval timeline for important therapies.
Nanoparticles are becoming more prevalent to overcome low solubility and poor permeability.